Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

$45.65
-8.31 (-15.4%)
HALO
NASDAQ Global Select
USD, US
Biotechnology
Product SegmentationGeographic Segmentation

Revenue Segmentation by product